>> Could this be a good reason why qlti may better compete against macugen than expected? And perhaps visudyne is the real competition for squalamine? <<
Some will agree with that, but not me. I believe that Visudyne is on its last legs and will be gone within five years.
Market Data 
Markets 
AI
